预测:2030年畅销药和世界药企排名

谈思生物
07 Jul

2025.07.07本文字数:1960,阅读时长大约4.9分钟导读:Evaluate最新报告预测,到2030年处方药总销售额将达1.75万亿美元,GLP-1疗法增长迅猛。礼来和诺和诺德凭借GLP-1明星药物Mounjaro、Zepbound、Ozempic等强势崛起,有望超越当前药企巨头,重塑行业格局。根据Evaluate的一份新报告,到2030年,处方药总销售额预计将增长到1.75万亿美元,预计...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10